Chih‐Wei Hsia

590 total citations
40 papers, 373 citations indexed

About

Chih‐Wei Hsia is a scholar working on Molecular Biology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chih‐Wei Hsia has authored 40 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Hematology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chih‐Wei Hsia's work include Platelet Disorders and Treatments (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Genomics, phytochemicals, and oxidative stress (9 papers). Chih‐Wei Hsia is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Genomics, phytochemicals, and oxidative stress (9 papers). Chih‐Wei Hsia collaborates with scholars based in Taiwan, India and United States. Chih‐Wei Hsia's co-authors include Joen‐Rong Sheu, Thanasekaran Jayakumar, Marappan Velusamy, Manjunath Manubolu, Periyakali Saravana Bhavan, Kao‐Chang Lin, Ting‐Lin Yen, Chi‐Li Chung, Duen‐Suey Chou and Cheng‐Ying Hsieh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Chih‐Wei Hsia

38 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih‐Wei Hsia Taiwan 12 138 62 58 46 43 40 373
Jagadeesh Kumar Gangasani India 14 152 1.1× 104 1.7× 43 0.7× 31 0.7× 39 0.9× 33 435
Gehan A. Hegazy Saudi Arabia 11 140 1.0× 47 0.8× 70 1.2× 44 1.0× 22 0.5× 31 500
Xiaonan Chen China 13 232 1.7× 47 0.8× 72 1.2× 62 1.3× 27 0.6× 30 402
Chunyan Fang China 9 166 1.2× 65 1.0× 47 0.8× 97 2.1× 25 0.6× 17 572
Karvannan Kanchana China 9 314 2.3× 65 1.0× 28 0.5× 27 0.6× 36 0.8× 22 548
Adio J. Akamo Nigeria 10 127 0.9× 49 0.8× 42 0.7× 23 0.5× 23 0.5× 32 357
Hassan N. Althurwi Saudi Arabia 14 123 0.9× 28 0.5× 80 1.4× 26 0.6× 22 0.5× 31 485
Mengjie Xiao China 14 280 2.0× 79 1.3× 48 0.8× 48 1.0× 62 1.4× 37 588
Yong‐Zhan Zhen China 14 212 1.5× 26 0.4× 63 1.1× 54 1.2× 33 0.8× 31 482
So Yong Lee South Korea 7 281 2.0× 39 0.6× 91 1.6× 44 1.0× 32 0.7× 7 455

Countries citing papers authored by Chih‐Wei Hsia

Since Specialization
Citations

This map shows the geographic impact of Chih‐Wei Hsia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Wei Hsia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Wei Hsia more than expected).

Fields of papers citing papers by Chih‐Wei Hsia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Wei Hsia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Wei Hsia. The network helps show where Chih‐Wei Hsia may publish in the future.

Co-authorship network of co-authors of Chih‐Wei Hsia

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Wei Hsia. A scholar is included among the top collaborators of Chih‐Wei Hsia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Wei Hsia. Chih‐Wei Hsia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hsia, Chih‐Wei, et al.. (2024). Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models. International Journal of Molecular Sciences. 25(4). 2098–2098. 8 indexed citations
3.
Hsia, Chih‐Wei, et al.. (2023). Garcinol acts as a novel integrin αIIbβ3 inhibitor in human platelets. Life Sciences. 326. 121791–121791. 4 indexed citations
4.
Jayakumar, Thanasekaran, Joen‐Rong Sheu, Kuo‐Ching Yuan, et al.. (2023). Anti-inflammatory Mechanism of Morin Hydrate by Suppressing the NF-κB/MAPKs Mediated Cell Migration and Modulating Src/FAK and β-Catenin. Natural Product Communications. 18(9). 1 indexed citations
5.
Jayakumar, Thanasekaran, et al.. (2023). Mechanisms of glabridin inhibition of integrin αIIbβ3 inside-out signals and NF-κB activation in human platelets. Chinese Medicine. 18(1). 71–71. 1 indexed citations
6.
Chang, Yi, et al.. (2023). Myricetin as a promising inhibitor of platelet fibrinogen receptor in humans. Heliyon. 9(10). e20286–e20286. 5 indexed citations
7.
Hsieh, Cheng‐Ying, Thanasekaran Jayakumar, Kao‐Chang Lin, et al.. (2023). Morin hydrate suppresses lipoteichoic acid-induced oxidative stress-mediated inflammatory events in macrophages via augmenting Nrf2/HO-1 and antioxidant defense molecules. SHILAP Revista de lepidopterología. 21. 5 indexed citations
8.
Wu, Ming‐Ping, Chih‐Wei Hsia, Thanasekaran Jayakumar, et al.. (2022). Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB. Molecules. 27(2). 476–476. 7 indexed citations
9.
Chung, Chi‐Li, et al.. (2022). Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice. International Journal of Molecular Sciences. 23(19). 11372–11372. 13 indexed citations
10.
Jayakumar, Thanasekaran, Chun‐Jen Huang, Ting‐Lin Yen, et al.. (2022). Activation of Nrf2 by Esculetin Mitigates Inflammatory Responses through Suppression of NF-κB Signaling Cascade in RAW 264.7 Cells. Molecules. 27(16). 5143–5143. 26 indexed citations
11.
Jayakumar, Thanasekaran, et al.. (2021). Anti-Inflammatory Mechanisms of Novel Synthetic Ruthenium Compounds. Applied Sciences. 11(21). 10092–10092. 8 indexed citations
12.
Jayakumar, Thanasekaran, Ming‐Ping Wu, Joen‐Rong Sheu, et al.. (2021). Involvement of Antioxidant Defenses and NF-κB/ERK Signaling in Anti-Inflammatory Effects of Pterostilbene, a Natural Analogue of Resveratrol. Applied Sciences. 11(10). 4666–4666. 11 indexed citations
13.
Chang, Chao-Chien, Thanasekaran Jayakumar, Marappan Velusamy, et al.. (2021). TQ-6, a Novel Ruthenium Derivative Compound, Possesses Potent Free Radical Scavenging Activity in Macrophages and Rats. Applied Sciences. 11(3). 1008–1008.
14.
Jayakumar, Thanasekaran, et al.. (2021). Targeting MAPK/NF-κB Pathways in Anti-Inflammatory Potential of Rutaecarpine: Impact on Src/FAK-Mediated Macrophage Migration. International Journal of Molecular Sciences. 23(1). 92–92. 34 indexed citations
15.
Hsia, Chih‐Wei, et al.. (2020). Regulation of Human Platelet Activation and Prevention of Arterial Thrombosis in Mice by Auraptene through Inhibition of NF-κB Pathway. International Journal of Molecular Sciences. 21(13). 4810–4810. 9 indexed citations
16.
17.
Hsia, Chih‐Wei, Kou‐Gi Shyu, Thanasekaran Jayakumar, et al.. (2019). Natural Coumarin Derivative Esculetin Regulates Platelet Activation via Modulating NF-κB Signaling in Cyclic Nucleotide-Independent Manner. Natural Product Communications. 14(12). 4 indexed citations
18.
Khamrang, Themmila, Joen‐Rong Sheu, Chih‐Wei Hsia, et al.. (2018). Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation. Bioinorganic Chemistry and Applications. 2018. 1–14. 2 indexed citations
19.
Jayakumar, Thanasekaran, Joen‐Rong Sheu, Marappan Velusamy, et al.. (2018). Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets. Molecules. 23(2). 477–477. 5 indexed citations
20.
Jayakumar, Thanasekaran, et al.. (2018). Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy. International Journal of Molecular Sciences. 19(6). 1818–1818. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jagadeesh Kumar Gangasani Breakdown of academic impact, for papers by Gehan A. Hegazy Breakdown of academic impact, for papers by Xiaonan Chen Breakdown of academic impact, for papers by Chunyan Fang Breakdown of academic impact, for papers by Karvannan Kanchana Breakdown of academic impact, for papers by Adio J. Akamo Breakdown of academic impact, for papers by Hassan N. Althurwi Breakdown of academic impact, for papers by Mengjie Xiao Breakdown of academic impact, for papers by Yong‐Zhan Zhen Breakdown of academic impact, for papers by So Yong Lee
Rankless by CCL
2026